ABACOPD is a randomized double blind placebo-controlled study to demonstrate that antibiotics are not needed in mild to moderate acute exacerbations of COPD.
Multicenter Study (Germany)
Approx. 25 centres
Chronic obstructive pulmonary disease (COPD)
The aim oh the clinical study is to demonstrate, that there is no relevant increase in the “failure-rate” for patients treated with placebo instead of antibiotic treatment both on top of standard of care. A patient is classified as an immediate treatment failure if additional antibiotic therapy is required during the treatment period or until the test of cure visit (primary endpoint).
Phase IV randomized double blind placebo-controlled multi-centre clinical trial